Forecast

There is no analyst data available for this company.

News Go to news feed

IMCD rises after strong half-year numbers — revenue, EBITA and free cash flow beat expectations

IMCD shares climbed 9.1% to €96.58 after results for H1 2026 were released. Operating EBITA for Q2 was €155.2m (consensus €146.0m) and organic revenue growth was 7.5% (consensus 5.0%). For the half-year, currency-adjusted EBITA rose to €285m (+8%), revenue reached €2,638m (+11% after exchange rate adjustments) and free cash flow increased 28% to €222m. CEO Marcus Jordan described the period positively and expressed confidence in further earnings growth; analyst updates, such as an upgrade by UBS, supported the rally. » More on de.investing.com
IMCD rises after UBS upgrade and price-target increase

UBS upgraded IMCD from “Neutral” to “Buy” and raised its price target from €85 to €100, after which the stock gained more than 5%. The bank sees a feasible path to organic EPS growth of 6–7%, supported by rising oil and chemical prices and ongoing supply-chain disruptions, which could add roughly 2% growth in 2026–27. UBS expects a slow volume recovery and a turnaround in revenue growth in Q2 2026, cites a bullish target of €140 and a negative scenario of €50. IMCD is currently trading at around 11x EV/EBITA for 2027; risks include cyclical industrial demand, regulatory and health-related issues, and fluctuations in product costs. » More on de.investing.com
IMCD exceeds Q1 EBITA thanks to growth in Asia-Pacific

IMCD reported an EBITA of €129.8 million for the first quarter of 2026, 9% below the prior year but 5% above the consensus estimate of €123.7 million. Organic sales fell 0.8%, while the Asia‑Pacific region grew by 3.5%; EMEA and the Americas saw declines. Gross and EBITA margins fell by 116 and 101 basis points respectively, though the EBITA margin of 10.2% was slightly above expectations. Free cash flow rose 19% to €121 million; leverage remained at 2.8 times EBITDA. IMCD does not provide guidance for 2026 but expects price increases, greater supply‑chain uncertainty and pressure on suppliers, and says it is well positioned. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, IMCD has already paid 1,81€ in dividends. The last payout was in May.

Financials

In the last quarter, IMCD had revenue of 2.64b€ and net profit of 142.34m€

(EUR)	Jun 2026	YoY
Revenue	+2.64b	-
Gross profit	+279.91m	-
Net profit	+142.34m	-
EBITDA	+306.45m	-

Fundamentals

Metric	Value
Market capitalization	+5.71b€
Number of shares	59.04m
52-week high/low	+105,05€ - +68,14€
Dividend yield	+1,86%
Dividends TTM	+1,81€
Beta	0,96
P/E ratio	+24,81
PEG ratio	−1,67
P/B ratio	+2,69
P/S ratio	+1,16

Company profile

IMCD N.V. vertreibt, vermarktet und verkauft Spezialchemikalien und Inhaltsstoffe in den Niederlanden, im übrigen Europa, im Nahen Osten, in Afrika, in Nordamerika, in Südamerika und im asiatisch-pazifischen Raum. Das Unternehmen bietet Enzyme, Tenside, Biozide, Chelate, Rheologiemodifikatoren, Lösungsvermittler, Silikone, Lösungsmittel und funktionelle Additive, pharmazeutische Wirkstoffe, Agrochemikalien, Biopharmazeutika, Hilfsstoffe und Formulierungen, Nutraceuticals und regulierte Synthese; Wirkstoffe, UV-Sonnenschutzmittel, Rheologiemodifikatoren, Verdickungsmittel, Emulgatoren, Weichmacher, Elastomere, Feuchthaltemittel, Wachse, Filmbildner, funktionelle Pulver, Haarstyling-Polymere, Haarspülungen, Lösungsmittel, Lösungsvermittler, Pigmente, Perlen, Farbstoffe, Trübungsmittel, Perlglanzmittel, Konservierungsmittel, Antioxidantien, Zusatzstoffe, Duftstoffe und ätherische Öle sowie Harze und Bindemittel, Zusatzstoffe, funktionelle Füllstoffe und Speziallösungsmittel. Darüber hinaus bietet das Unternehmen Geschmack, Textur, Nährwert und Funktion; Grundöl, süchtig machende Kraftstoffe, süchtig machende Schmierstoffe, fertige Schmierstoffe, Lösungsmittel, Entfetter und Kraftstoffe, Verbindungen und Upstream-, Midstream- und Downstream-Öl, Gas und Energie; biobasierte Chemikalien, Katalysatoren, Zwischenprodukte, Monomere, organische Bausteine, Verarbeitungshilfsmittel, reaktive Verdünnungsmittel, Lösungsmittel und Tenside. IMCD N.V. wurde 1995 gegründet und hat seinen Hauptsitz in Rotterdam, Niederlande.